Assessment of Lurasidone Hydrochloride and Its Impurities for Neuronal and Cardiac Toxicities Using Integrated Toxicological Approaches
Journal of Applied Toxicology · 21.10.2026
DOI: 10.1002/jat.70480 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Toxicology, online erschienen am 21.10.2026. Verfasst von Arya Patel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Ramanbhai Patel College of Pharmacy, CHARUSAT, Changa, India. Die Arbeit nennt 63 Literaturangaben. Gefördert von: CHARUSAT Seed Research Grant.
Abstract (Originalsprache)
Lurasidone hydrochloride (LH) has over 98 other impurities produced during its manufacturing and storage process. LH had two crucial impurities that were reported cytotoxic and genotoxic in nature: 4‐chloro‐1,2‐benzisothiazole (Impurity 1) and 3‐(1‐piperazinyl)‐1,2‐benzisothiazole (Impurity 2). When the impurity threshold is exceeded due to chronic administration, evaluation of the toxicity of critical organs become crucial. A variety of endpoints were evaluated to assess the neurotoxicity of LH along with both impurities. The parameters related to neurotoxicity includes assessment of neurobehavioral abnormalities, evaluation of acetylcholinesterase and oxidative stress level by super oxide dismutase and malondialdehyde. Acetylcholinesterase is the most desirable targets affected by both impurities, according to AI‐based toxicity prediction tools and docking scores. Cytotoxic nature of LH's and its impurities were discovered at 80‐, 160‐, and 320‐μM concentrations through in vitro study with PC12 and H9C2 cell lines. In zebrafish study, at 0.2 μg/L of Impurity 2, there was an increase in mirror biting and time spent at the bottom of the tank, but there was no discernible decline in memory or learning during the T‐maze assay. Impurity 1 and Impurity 2 demonstrated inhibition of AchE at the molecular level, which raises acetylcholine levels and causes excitotoxicity. Oxidative damage in neuronal cells is indicated by a lower amount of superoxide dismutase and a higher level of malondialdehyde. Cardiac histological damages like exhibiting myofilament fiber rupture and dissolution observed to decide toxicity induced damage. At 0.2‐μg/L dose, the Impurity 2 has shown potential neurotoxicity as well cardiotoxicity in zebrafish study.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, Ramanbhai Patel College of Pharmacy, CHARUSAT, Changa, India.
- Department of Pharmaceutical Chemistry, Ramanbhai Patel College of Pharmacy, CHARUSAT, Changa, India.
- Department of Pharmaceutical Chemistry and Analysis, Gandhinagar Institute of Pharmacy, Gandhinagar University, Gandhinagar, Gujarat, India.
- Department of Machine Learning, Smt. Chandaben Mohanbhai Patel Institute of Computer Applications (CMPICA), CHARUSAT, Changa, Gujarat, India.
- Anatomical Pathologist, Vadodara clinical laboratory, Vadodara, Gujarat, India.
ORCID-Profile: Arya Patel, Umang Shah, Archita Patel, Anjali Mahavar, Sahil Panjvani, Alkeshkumar Patel
Förderung
- CHARUSAT Seed Research Grant
Zitieren
APA
Patel, A., Patel, N., Shah, U., Patel, A., Mahavar, A., Panjvani, S., & Patel, A. (2026). Assessment of Lurasidone Hydrochloride and Its Impurities for Neuronal and Cardiac Toxicities Using Integrated Toxicological Approaches. Journal of Applied Toxicology. https://doi.org/10.1002/jat.70480
Vancouver
Patel A, Patel N, Shah U, Patel A, Mahavar A, Panjvani S, et al. Assessment of Lurasidone Hydrochloride and Its Impurities for Neuronal and Cardiac Toxicities Using Integrated Toxicological Approaches. Journal of Applied Toxicology. 2026. doi:10.1002/jat.70480
BibTeX
@article{Patel2026,
author = {Patel, Arya and Patel, Nehangi and Shah, Umang and Patel, Archita and Mahavar, Anjali and Panjvani, Sahil and Patel, Alkeshkumar},
title = {Assessment of Lurasidone Hydrochloride and Its Impurities for Neuronal and Cardiac Toxicities Using Integrated Toxicological Approaches},
journal = {Journal of Applied Toxicology},
year = {2026},
doi = {10.1002/jat.70480}
}
EUVIMED